Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.


Krämer A., Bochtler T., Pauli C., Shiu K., Cook N., Janoski de Menezes J., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026 (SCI-Expanded, Scopus)